RAYMOND JAMES & ASSOCIATES - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$279,000
+39.5%
6,154
+8.7%
0.00%
Q3 2020$200,000
-7.4%
5,662
-1.1%
0.00%
Q2 2020$216,000
-29.4%
5,727
-3.0%
0.00%
Q4 2019$306,000
-6.4%
5,905
-1.0%
0.00%
Q3 2019$327,000
+9.7%
5,963
-18.8%
0.00%
Q2 2019$298,000
+27.9%
7,343
-4.9%
0.00%
Q1 2019$233,000
+13.1%
7,721
+26.1%
0.00%
Q4 2018$206,000
-33.8%
6,121
-17.1%
0.00%
Q3 2018$311,000
+26.9%
7,380
-3.6%
0.00%
Q2 2018$245,000
+18.4%
7,658
+84.1%
0.00%
Q1 2018$207,000
-37.1%
4,160
-69.8%
0.00%
-100.0%
Q3 2013$329,000
+46.9%
13,787
+4.6%
0.00%
+50.0%
Q2 2013$224,00013,1860.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders